XML 23 R14.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Note 7 - Net Loss Per Share
6 Months Ended
Jun. 30, 2024
NET LOSS PER SHARE  
Net Loss Per Share

7. Net Loss Per Share

A reconciliation of the components of basic and diluted net loss per share of common stock is presented below:

 

Three Months Ended June 30,

 

 

2024

 

 

2023

 

 

 

 

 

Weighted
Average

 

 

Loss

 

 

 

 

 

Weighted
Average

 

 

Loss Per

 

 

Net Loss

 

 

Shares

 

 

Per Share

 

 

Net Loss

 

 

Shares

 

 

Share

 

Basic Net Loss per Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to common stock

 

$

(18,545,753

)

 

 

9,775,758

 

 

$

(1.90

)

 

$

(10,415,512

)

 

 

7,547,472

 

 

$

(1.38

)

Diluted Net Loss per Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to common stock

 

$

(18,545,753

)

 

 

9,775,758

 

 

$

(1.90

)

 

$

(10,415,512

)

 

 

7,547,472

 

 

$

(1.38

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended June 30,

 

 

2024

 

 

2023

 

 

 

 

 

Weighted
Average

 

 

Loss

 

 

 

 

 

Weighted
Average

 

 

Loss Per

 

 

Net Loss

 

 

Shares

 

 

Per Share

 

 

Net Loss

 

 

Shares

 

 

Share

 

Basic Net Loss per Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to common stock

 

$

(39,042,992

)

 

 

9,681,064

 

 

$

(4.03

)

 

$

(18,340,999

)

 

 

7,455,691

 

 

$

(2.46

)

Diluted Net Loss per Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to common stock

 

$

(39,042,992

)

 

 

9,681,064

 

 

$

(4.03

)

 

$

(18,340,999

)

 

 

7,455,691

 

 

$

(2.46

)

 

Options and warrants to purchase 866,875 shares of common stock of the Company were outstanding as of June 30, 2024, and 501,000 shares as of June 30, 2023. These options and warrants were not included in the computation of diluted earnings per share for the three and six month periods ended June 30, 2024 and 2023 due to being anti-dilutive.